AlphAIAlphAI — Financial news for AI agents
Business WireMAY 14 min read$OSPN

OneSpan Reports First Quarter 2026 Financial Results

OneSpan Inc. reported its first-quarter 2026 financial results, with total revenue increasing 4% year-over-year to $65.9 million and subscription revenue growing 8% to $52.7 million. The company also announced the acquisition of Build38 to strengthen its cybersecurity offerings and updated its full-year 2026 financial guidance, increasing its ARR expectations. OneSpan's CEO highlighted solid profitability and subscription revenue growth and emphasized continued focus on efficient growth, strong profitability, cash generation, and returning capital to shareholders.

Original reporting
Business Wire
Published May 1, 2026, 3:38 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI May 1, 2026, 4:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefFinancial news
Primary signal
$OSPN
Bullish
high confidence
Mentioned
$OSPN
Relevance
6/10
AlphAI data visualization · based on Business Wire
Decision brief

The 30-second read

$OSPNBullishHigh
01

Why it matters

The company's focus on profitability and shareholder returns may attract investor interest, supporting stock appreciation.

02

Market read

The news indicates positive momentum in the cybersecurity and fintech sectors, with potential ripple effects on related stocks.

03

What to watch

Rising interest rates could pressure valuations; competitive pressures may impact future growth.

Relevance 6/10Timing: Immediate to short-term (next 1-3 months)

Background

OneSpan's Q1 2026 results show resilience amid a competitive cybersecurity landscape, with strategic acquisitions boosting growth prospects.

Company-level read

Ticker impact

$OSPNBullishHigh confidence
Context

High relevance due to positive financial results and strategic acquisition.

Expected impact

Potential 5-8% increase over the next 1-3 months.

Evidence & confidence

Consistent revenue growth, strategic acquisitions, and positive guidance support bullish outlook. The company's focus on profitability and shareholder returns further reinforce this view.

Market effects

Sector

Strengthening of cybersecurity and financial technology sectors.

Regional

Positive impact on US-based fintech and cybersecurity stocks.

Global

Moderate; potential influence on global cybersecurity industry trends.

Counterpoint

What could challenge this read

Market may have already priced in the good news; potential for short-term profit-taking leading to a temporary dip.

Key entities

  • Company
    OneSpan Inc.

    A provider of digital identity and anti-fraud solutions.

  • Acquisition Target
    Build38

    Cybersecurity firm acquired to enhance OneSpan's product offerings.

Read at source← All news

Related articles

SEP 9
$OSPNMed

OneSpan’s (OSPN) Subscription Growth Masks A Shrinking Bottom Line

OneSpan (OSPN) reported Q2 2026 revenue of $60.5M, up 1% YoY. Subscription revenue grew 11% to $46.7M, while operating income fell 17% to $8.7M. The company raised full-year guidance, expecting $248M-$252M in revenue and $67M-$71M in Adjusted EBITDA. Net income declined to $6.8M, or $0.18 per share, from $8.3M a year earlier.

yahoo.com2 min
AUG 12
$OSPNMedAI 8/10

OneSpan (OSPN) Q2 2026 Earnings Call Transcript

OneSpan (OSPN) reported Q2 2026 revenue of $60.5 million, up 1% year over year, with subscription revenue at $46.7 million (+11%) and ARR of $189.7 million (+7%). Adjusted EBITDA was $16.9 million (28% margin). Full-year guidance raised to revenue $248-$252 million and adjusted EBITDA $67-$71 million. The company also launched DigipassONE and returned $2.9 million via repurchases.

fool.com6 min
AUG 4
$OSPNMed

OneSpan Reports Second Quarter 2026 Financial Results

OneSpan Inc. (OSPN) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 OneSpan Reports Second Quarter 2026 Financial Results • Revenue increased 1% year-over-year to $60.5 million • Subscription revenue increased 11% year-over-year to $46.7 million • Operating income decreased 17% year-over-year to $8.7 million • Adjusted EBITDA decreas

SEC EDGAR 8-K7 min
OCT 24
$CLYMHighAI 8/10

Climb Bio reports early data on budoprutug for kidney diseases

Climb Bio (CLYM) presented Phase 2 trial data for budoprutug, an anti-CD19 antibody, showing B-cell depletion and PLA2R antibody reductions in kidney disease patients. The 200 mg dose achieved 70% mean antibody reduction, with 5/13 patients in remission. The 600 mg dose showed deeper B-cell depletion. The drug was well-tolerated. Climb Bio expects more data in 2027. Primary membranous nephropathy affects 75,000 people in the U.S. without FDA-approved treatments.

investing.com2 min